205 related articles for article (PubMed ID: 18197798)
1. CD8+ memory T lymphocytes from bone marrow--immune function and therapeutic potential.
Wood AH; Zhang X; Farber DL; Strome SE
Crit Rev Immunol; 2007; 27(6):527-37. PubMed ID: 18197798
[TBL] [Abstract][Full Text] [Related]
2. Linear differentiation of cytotoxic effectors into memory T lymphocytes.
Opferman JT; Ober BT; Ashton-Rickardt PG
Science; 1999 Mar; 283(5408):1745-8. PubMed ID: 10073942
[TBL] [Abstract][Full Text] [Related]
3. CMV-specific central memory T cells reside in bone marrow.
Letsch A; Knoedler M; Na IK; Kern F; Asemissen AM; Keilholz U; Loesch M; Thiel E; Volk HD; Scheibenbogen C
Eur J Immunol; 2007 Nov; 37(11):3063-8. PubMed ID: 17960663
[TBL] [Abstract][Full Text] [Related]
4. Human bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function.
Zhang X; Dong H; Lin W; Voss S; Hinkley L; Westergren M; Tian G; Berry D; Lewellen D; Vile RG; Chen L; Farber DL; Strome SE
J Immunol; 2006 Nov; 177(10):6730-7. PubMed ID: 17082586
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
6. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
7. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
8. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow.
Parretta E; Cassese G; Barba P; Santoni A; Guardiola J; Di Rosa F
J Immunol; 2005 Jun; 174(12):7654-64. PubMed ID: 15944266
[TBL] [Abstract][Full Text] [Related]
9. Peripheral and systemic antigens elicit an expandable pool of resident memory CD8
Pascutti MF; Geerman S; Collins N; Brasser G; Nota B; Stark R; Behr F; Oja A; Slot E; Panagioti E; Prier JE; Hickson S; Wolkers MC; Heemskerk MHM; Hombrink P; Arens R; Mackay LK; van Gisbergen KPJM; Nolte MA
Eur J Immunol; 2019 Jun; 49(6):853-872. PubMed ID: 30891737
[TBL] [Abstract][Full Text] [Related]
10. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
11. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15.
Snell LM; Lin GH; Watts TH
J Immunol; 2012 Jun; 188(12):5915-23. PubMed ID: 22581858
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.
Rubinstein MP; Kadima AN; Salem ML; Nguyen CL; Gillanders WE; Cole DJ
J Immunol; 2002 Nov; 169(9):4928-35. PubMed ID: 12391205
[TBL] [Abstract][Full Text] [Related]
13. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
14. A Context-Dependent Role for IL-21 in Modulating the Differentiation, Distribution, and Abundance of Effector and Memory CD8 T Cell Subsets.
Tian Y; Cox MA; Kahan SM; Ingram JT; Bakshi RK; Zajac AJ
J Immunol; 2016 Mar; 196(5):2153-66. PubMed ID: 26826252
[TBL] [Abstract][Full Text] [Related]
15. Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells.
Herndler-Brandstetter D; Landgraf K; Jenewein B; Tzankov A; Brunauer R; Brunner S; Parson W; Kloss F; Gassner R; Lepperdinger G; Grubeck-Loebenstein B
J Immunol; 2011 Jun; 186(12):6965-71. PubMed ID: 21562158
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: rapid in vivo killing by memory CD8 T cells.
Barber DL; Wherry EJ; Ahmed R
J Immunol; 2003 Jul; 171(1):27-31. PubMed ID: 12816979
[TBL] [Abstract][Full Text] [Related]
17. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques.
Halwani R; Boyer JD; Yassine-Diab B; Haddad EK; Robinson TM; Kumar S; Parkinson R; Wu L; Sidhu MK; Phillipson-Weiner R; Pavlakis GN; Felber BK; Lewis MG; Shen A; Siliciano RF; Weiner DB; Sekaly RP
J Immunol; 2008 Jun; 180(12):7969-79. PubMed ID: 18523260
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.
Byers AM; Kemball CC; Moser JM; Lukacher AE
J Immunol; 2003 Jul; 171(1):17-21. PubMed ID: 12816977
[TBL] [Abstract][Full Text] [Related]
20. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
Hu HM; Winter H; Urba WJ; Fox BA
J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
